Ireland Cuts Drug Prices And May Also Introduce Reference Pricing
Ireland slashed the prices of 300 branded multisource medicines, including Zofran and Casodex, by around 40 percent at the start of the month, and there are strong indications that more cutbacks are to follow, with reference pricing and generic substitution as distinct possibilities
More from Europe
Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to include two new products, one of which is Tepezza, Amgen's treatment for moderate to severe thyroid eye disease.
Vincenza Trivigno will take over as executive director from Raimund Bruhin, who is retiring after over seven years in the post.
Stefan Oelrich, the newly-announced president of European pharma industry federation EFPIA says the EU pharma reform is “not an improvement on the status quo” in its current form.